BioAlert Solutions Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
27
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$1.74M
- Investors
-
8
BioAlert Solutions General Information
Description
Developer of a water quality monitoring device designed to control the proliferation of pathogens in industrial waters. The company's device detects the presence of bacteria directly at the cooling system site, can be controlled by a remote and sends alarm signals directly to the person in charge, enabling businesses to have a reliable and economical monitoring alternative.
Contact Information
Website
www.bioalert.caCorporate Office
- 2650, Maximilien-Chagnon Street
- Suite 4
- Sherbrooke, Quebec J1E 0M8
- Canada
Corporate Office
- 2650, Maximilien-Chagnon Street
- Suite 4
- Sherbrooke, Quebec J1E 0M8
- Canada
BioAlert Solutions Timeline
BioAlert Solutions Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 27-Mar-2025 | $1.74M | Completed | Generating Revenue | ||
| 4. Accelerator/Incubator | 01-Jan-2025 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 02-Dec-2021 | Completed | Generating Revenue | |||
| 2. Later Stage VC | 22-Nov-2019 | $1.5M | $1.5M | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 01-Jan-2019 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
BioAlert Solutions Patents
BioAlert Solutions Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2017393112-A1 | Analytical device and method for assessing analyte within a sample | Active | 16-Jan-2017 | ||
| AU-2017393112-B2 | Analytical device and method for assessing analyte within a sample | Active | 16-Jan-2017 | ||
| CA-3050162-A1 | Analytical device and method for assessing analyte within a sample | Active | 16-Jan-2017 | ||
| EP-3568686-A1 | Analytical device and method for assessing analyte within a sample | Pending | 16-Jan-2017 | ||
| EP-3568686-A4 | Analytical device and method for assessing analyte within a sample | Pending | 16-Jan-2017 | G01N1/40 |
BioAlert Solutions Signals
BioAlert Solutions Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cycle Capital Management | Venture Capital | Minority | ||
| Fondaction | Growth/Expansion | Minority | ||
| GreenSky Ventures | Venture Capital | Minority | ||
| Spring Impact Capital | Impact Investing | Minority | ||
| Québec Tech | Accelerator/Incubator |
BioAlert Solutions FAQs
-
When was BioAlert Solutions founded?
BioAlert Solutions was founded in 2014.
-
Where is BioAlert Solutions headquartered?
BioAlert Solutions is headquartered in Sherbrooke, Canada.
-
What is the size of BioAlert Solutions?
BioAlert Solutions has 27 total employees.
-
What industry is BioAlert Solutions in?
BioAlert Solutions’s primary industry is Electronic Equipment and Instruments.
-
Is BioAlert Solutions a private or public company?
BioAlert Solutions is a Private company.
-
What is BioAlert Solutions’s current revenue?
The current revenue for BioAlert Solutions is .
-
How much funding has BioAlert Solutions raised over time?
BioAlert Solutions has raised $4.14M.
-
Who are BioAlert Solutions’s investors?
Cycle Capital Management, Fondaction, GreenSky Ventures, Spring Impact Capital, and Québec Tech are 5 of 8 investors who have invested in BioAlert Solutions.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process